Key result
Key issues following ventricular assist device implantation include preventing right ventricular failure, appropriate pharmacologic management, and managing infection and device dysfunction.
Answers are grounded in this paper and cite their sources.
Provides an overview of key management issues following LVAD implantation, including right ventricular failure, pharmacotherapy, infection, and device dysfunction.
The implantation of ventricular assist devices allows the opportunity for patients with intractable heart failure to have improved quality and quantity of life. The devices may be implanted after failed attempts to wean from bypass, as a bridge to transplantation, or as destination therapy. Key issues following the implantation of assist devices include the prevention of right ventricular failure, appropriate pharmacologic management, prevention and management of infection, and detection and treatment of device dysfunction.
No takes yet. Share an insight, caveat, or question.
Klodell et al. (2006) conducted a review in Intractable heart failure. Ventricular assist devices was evaluated. Key issues following ventricular assist device implantation include preventing right ventricular failure, appropriate pharmacologic management, and managing infection and device dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: